Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

• Hong-guang Wang,
• Hong-guang Wang,
• Hong-guang Wang,
• Hong-guang Wang,
• Hua Yan,
• Hua Yan,
• Chen Wang,
• Chen Wang,
• Mi-mi Li,
• Xin-ze Lv,
• Hai-dong Wu,
• Zhan-hai Fang,
• Dong-li Mo,
• Dong-li Mo,
• Zhi-yuan Zhang,
• Bin Liang,
• Ke-guan Lai,
• Jing-yu Bao,
• Xue-jia Yang,
• Hong-juan Zhao,
• Shuang Chen,
• Yi-mu Fan,
• Yi-mu Fan,
• Yi-mu Fan,
• Xiao-guang Tong,
• Xiao-guang Tong,
• Xiao-guang Tong

Affiliations

Hong-guang Wang

College of Pharmacy, Nankai University, Tianjin, China

Hong-guang Wang

Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Hong-guang Wang

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Hong-guang Wang

Tianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Hua Yan

Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Hua Yan

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Chen Wang

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Chen Wang

Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Mi-mi Li

Tianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Xin-ze Lv

Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Hai-dong Wu

Tianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Zhan-hai Fang

Department of Neurosurgery, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, China

Dong-li Mo

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Dong-li Mo

Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Zhi-yuan Zhang

Tianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Bin Liang

Tianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Ke-guan Lai

Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Jing-yu Bao

Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Xue-jia Yang

Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Hong-juan Zhao

Department of Respiratory Medicine, Songjiang Sijing Hospital, Shanghai, China

Shuang Chen

Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Yi-mu Fan

Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Yi-mu Fan

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Yi-mu Fan

Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China

Xiao-guang Tong

Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China

Xiao-guang Tong

Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China

Xiao-guang Tong

Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China